Business Description
Cell Source Inc
NAICS : 325413
SIC : 2834
ISIN : US15114L1044
Description
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. The other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched as well as mismatched organ transplantation.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.52 | |||||
9-Day RSI | 55.53 | |||||
14-Day RSI | 53.42 | |||||
3-1 Month Momentum % | 7.34 | |||||
6-1 Month Momentum % | 64 | |||||
12-1 Month Momentum % | 203.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -17.8 | |||||
EV-to-EBITDA | -17.8 | |||||
EV-to-FCF | -22.71 | |||||
Earnings Yield (Greenblatt) % | -5.62 | |||||
FCF Yield % | -5.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CLCS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cell Source Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.13 | ||
| Beta | -342.1505 | ||
| 3-Year Sharpe Ratio | 0.78 | ||
| 3-Year Sortino Ratio | 341.09 | ||
| Volatility % | 87.13 | ||
| 14-Day RSI | 53.42 | ||
| 14-Day ATR ($) | 0.053959 | ||
| 20-Day SMA ($) | 0.795285 | ||
| 12-1 Month Momentum % | 203.7 | ||
| 52-Week Range ($) | 0.2322 - 2.25 | ||
| Shares Outstanding (Mil) | 67.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cell Source Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cell Source Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cell Source Inc Frequently Asked Questions
What is Cell Source Inc(CLCS)'s stock price today?
The current price of CLCS is $0.75. The 52 week high of CLCS is $2.25 and 52 week low is $0.23.
When is next earnings date of Cell Source Inc(CLCS)?
The next earnings date of Cell Source Inc(CLCS) is .
Does Cell Source Inc(CLCS) pay dividends? If so, how much?
Cell Source Inc(CLCS) does not pay dividend.
Guru Commentaries on OTCPK:CLCS
No articles.
Press Release
Articles on Cell Source Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers